New research reveals that patients who come off popular weight-loss injections like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who stop traditional diet and exercise programs.
Findings released in a prominent medical journal demonstrates that while obese people can lose a large proportion of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Users using these medications should be aware of the danger of quick weight regain when the medication ends," warns expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment mass within about a year and a half.
Weighing Approaches
The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.
Scientists point out that people who lose weight through lifestyle changes alone usually have a more gradual weight regain—around 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Nutrition scientists believe the way of the injections accounts for the amplified regain.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in appetite is uncontrolled, making binge eating much more probable."
A Chronic Issue?
The NHS advise the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the high risk of weight regain, the treatment is often life-long.
This perspective is reinforced by pharmaceutical companies, who state that the results "underscore the persistent character of obesity," comparing it to managing conditions like diabetes.
Patient Testimonies
Individuals who have discontinued the medication describe a powerful return of cravings.
"I experienced something flipping and you're instantly starving," recalled one woman.
This challenge is exacerbated if users have not adopted sustainable dietary or behavioural modifications during therapy.
Significant Use
Survey data indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is more common among women compared to males.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts caution that while these medications are potent agents for weight loss, they are not a permanent cure and long-term success hinges on integrated behavioural changes.
